SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,502 JPY | +1.49% |
|
+5.55% | -11.54% |
Chart calendar Shin Nippon Biomedical Laboratories, Ltd.
c551ea2.RrROBXbdUHDODPblPXmOFNzvXPAs_1yhHN80QRiC19Y.BIQfQBusKQaYOruQb0y_V7i6Cp5UvDSQTewNO3fjsJAy_3xjALoXE4N5sw~7f26fe75cee9b0b5ec1af3c0bc053ab5
Upcoming events on Shin Nippon Biomedical Laboratories, Ltd.
Past events on Shin Nippon Biomedical Laboratories, Ltd.
| 2024-03-27 | Final dividend |
| 2024-02-01 | Q3 2023 Earnings Release |
| 2023-11-06 | Q2 2023 Earnings Release |
| 2023-09-27 | Ex-dividend day for dividende intermédiaire |
| 2023-08-01 | Q1 2023 Earnings Release |
| 2023-05-07 | Q4 2022 Earnings Release |
| 2023-03-29 | Ex-dividend day for final dividend |
| 2023-01-30 | Q3 2022 Earnings Release |
| 2022-10-30 | Interim 2022 Earnings Release |
| 2022-09-28 | Ex-dividend day for dividende intermédiaire |
| 2022-07-28 | Q1 2022 Earnings Release |
| 2022-05-05 | FY 2021 Earnings Release |
| 2022-03-29 | Ex-dividend day for extraordinary dividend |
| 2022-03-29 | Ex-dividend day for final dividend |
| 2022-02-01 | Q3 2021 Earnings Release |
| 2021-11-01 | Interim 2021 Earnings Release |
| 2021-08-03 | Q1 2022 Earnings Release |
| 2021-05-09 | FY 2020 Earnings Release |
| 2021-03-29 | Ex-dividend day for extraordinary dividend |
| 2021-03-29 | Ex-dividend day for final dividend |
Past dividends on Shin Nippon Biomedical Laboratories, Ltd.
| 2024-03-27 | Final Payment 30 JPY |
| 2023-09-27 | Interim Payment 20 JPY |
| 2023-03-29 | Final Payment 30 JPY |
| 2022-09-28 | Interim Payment 20 JPY |
| 2022-03-29 | Final Payment 30 JPY |
| 2022-03-29 | Bonus Payment 10 JPY |
| 2021-03-29 | Final Payment 10 JPY |
| 2021-03-29 | Bonus Payment 10 JPY |
| 2020-03-29 | 5 JPY |
| 2019-03-26 | 3 JPY |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 15 658 | 14 561 14 500 0.42% | 15 110 | 17 748 17 900 -0.85% | 25 090 25 063 0.11% | 26 190 |
|
EBITDA Million JPY | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 6 789 6 830 -0.61% | 5 540 |
|
EBIT Million JPY | Released Forecast Spread | 829 | 2 228 2 200 1.27% | 2 529 | 4 195 4 100 2.32% | 5 245 5 470 -4.12% | 3 470 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 1 650 | 3 062 0,00 - | 4 175 | 8 183 0,00 - | 7 759 7 862 -1.3% | 5 490 |
|
Net income Million JPY | Released Forecast Spread | 1 950 | 2 550 1 400 82.14% | 3 661 | 7 127 5 800 22.88% | 6 060 5 651 7.23% | 3 975 |
|
EPS JPY | Released Forecast Spread | 46,8 | 61,3 50,4 21.53% | 88,0 | 171 139 22.9% | 146 128 13.36% | 95,5 |
| Announcement Date | 10/05/19 | 11/05/20 | 10/05/21 | 06/05/22 | 08/05/23 | - |
Quarterly results
| Fiscal Period | March | 2020 S1 | 2021 S1 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 6 389 | 7 003 | 7 961 | 4 985 | 4 046 4 000 1.15% | 6 302 6 523 -3.39% | 10 348 10 570 -2.1% | 6 023 6 201 -2.87% | 8 718 8 628 1.05% | 5 805 5 500 5.54% | 6 079 7 195 -15.51% | 11 884 13 000 -8.58% | 6 100 8 416 -27.52% | 8 205 | 7 300 | 7 400 | 14 700 | 7 550 | 9 250 |
|
EBIT Million JPY | Released Forecast Spread | 1 078 | 1 161 | 1 969 | 1 331 | 714 950 -24.84% | 1 599 1 836 -12.91% | 2 313 2 550 -9.29% | 1 470 1 486 -1.08% | 1 461 1 616 -9.58% | 1 227 700 75.3% | 1 122 1 172 -4.23% | 2 349 2 400 -2.11% | 186 1 450 -87.17% | 934 | 1 000 | 950 | 1 950 | 850 | 1 700 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 1 252 | 1 300 | 3 905 | 2 139 | 2 771 2 150 28.88% | 3 119 2 127 46.63% | 5 890 4 900 20.2% | -259 1 971 -113.14% | 2 128 1 519 40.11% | 1 941 1 100 76.45% | 1 872 1 722 8.74% | 3 814 3 600 5.94% | 1 124 2 043 -44.98% | 1 600 | 1 550 | 3 150 | 1 850 | 2 100 | |
|
Net income Million JPY | Released Forecast Spread | 877 | 1 139 | 3 503 | 1 744 | 1 944 1 565 24.22% | 2 475 1 665 48.65% | 4 419 3 610 22.41% | -68,0 1 590 -104.28% | 1 708 948 80.19% | 1 373 750 83.11% | 1 593 1 146 38.99% | 2 966 2 520 17.71% | 828 1 123 -26.27% | 180 | 1 200 | 1 170 | 2 370 | 1 510 | 1 420 |
|
EPS JPY | Released Forecast Spread | 21,1 | 27,4 | 84,2 | 41,9 | 46,7 | 106 | -1,64 | 41,0 26,4 55.22% | 33,0 20,3 62.54% | 38,3 27,0 41.86% | 71,2 | 19,9 41,0 -51.49% | |||||||
| Announcement Date | 08/11/19 | 06/11/20 | 02/11/21 | 02/02/22 | 29/07/22 | 31/10/22 | 31/10/22 | 31/01/23 | 08/05/23 | 02/08/23 | 07/11/23 | 07/11/23 | 02/02/24 | - | - | - | - | - | - |
More events
Past sector events for Shin Nippon Biomedical Laboratories, Ltd.
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 2395 Stock
- Calendar Shin Nippon Biomedical Laboratories, Ltd.
